In collaboration with MCPHS University, the Global Medical Information & Review Fellowship is a one-year program designed to provide the Fellows with opportunities to develop core competencies in Medical Information. This will be accomplished while also learning about the pharmaceutical industry by working cross-functionally within Global Medical Affairs Oncology in addition to Marketing, Regulatory Affairs, Legal, Safety, as well as with field-based Medical Science Liaisons. Additionally, the fellows will have the opportunity to gain valuable experiences within the broader Medical Communications teams, including Disease & Product Training, Medical Education, and Publications.
Become proficient in searching internal and external resources, and evaluating scientific data to develop evidence-based medical content to answer US and Global queries
Enhance medical writing expertise and knowledge through researching, creating, updating, and reviewing materials and ensuring global consistency of Medical Information & Training resources
Participate in the medical/scientific review of non-promotional materials as part of a multidisciplinary team
Attend medical conferences and participate in Medical Information & responsibilities associated with these events
Gain a better understanding of Medical and Commercial initiatives by building relationships with cross functional colleagues through interaction with external (call center vendors) and internal US and Global teams (Medical Affairs, Regulatory Affairs, Legal, Commercial, Clinical and Pharmacovigilance) and by identifying emerging insights from customer inquiries
Gain a comprehensive understanding of adverse events, product quality, and other important safety information
Assist on highly visible projects, as needed
To be considered for an interview at Midyear, please register for both ASHP Midyear and PPS and then complete a fellowship application on the MCPHS Fluid Review application portal. Visit https://mcphs.fluidreview.com/
Please DO NOT request an interview within PPS. Our recruitment teams will contact qualified candidates via PPS to schedule interviews.
Before ASHP Midyear Clinical Meeting
Applicants must upload the following application materials to the online portal prior to December 2, 2019:
Letter of intent
Unofficial college transcript
Contact information of three references for letters of recommendation.
Incomplete applications WILL NOT be reviewed. ASHP Clinical Midyear Meeting interviews CANNOT be scheduled until these materials have been submitted. Please keep in mind that this is a competitive process and applicants are encouraged to complete their applications as soon as possible.
After ASHP Midyear Clinical Meeting
The three letters of recommendation must be submitted by the three provided contacts no later than December 16th
Top candidates will be invited for onsite interviews at the sponsoring company’s location. Final candidates will be required to go through additional screening / onboarding as required by MCPHS University.
The MCPHS Biopharmaceutical Industry fellows will be selected on a nationally competitive basis, with interviews at the American Society of Health Systems Pharmacists (ASHP) Midyear meeting.
Applicants must have a Doctor of Pharmacy degree from an ACPE accredited college of pharmacy at the commencement of the program.
Candidates must have strong written and verbal communication skills and a strong interest in pursuing a career within the biopharmaceutical industry.
All candidates must have authorization to work in the United States throughout the duration of the one or two-year fellowship. No visa sponsorship will be provided.
Employer will assist with relocation costs.
Additional Salary Information: Fellows will receive a competitive stipend and benefit package, including comprehensive health insurance.
About Takeda Pharmaceuticals International Co.
Takeda is a global pharmaceutical company founded in 1781 with headquarters in Osaka, Japan, and operations in more than 70 countries and regions worldwide, representing Japan, the United States, Europe, Latin America, Africa, the Middle East, and the Asia Pacific Region. Takeda's pharmaceutical products are marketed in around 100 countries worldwide, including partnerships (marketing alliance partners). The company has grown in size and scope both organically and through acquisition.